MassMutual Private Wealth & Trust FSB bought a new position in JPMorgan U.S. Research Enhanced Large Cap ETF (NYSEARCA:JUSA – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 22,329 shares of the company’s stock, valued at approximately $1,500,000. MassMutual Private Wealth & Trust FSB owned approximately 0.36% of JPMorgan U.S. Research Enhanced Large Cap ETF at the end of the most recent quarter.
Separately, Goldman Sachs Group Inc. bought a new position in shares of JPMorgan U.S. Research Enhanced Large Cap ETF during the fourth quarter valued at $391,000.
JPMorgan U.S. Research Enhanced Large Cap ETF Price Performance
JUSA opened at $69.72 on Wednesday. The firm has a market cap of $705.57 million, a PE ratio of 26.08 and a beta of 0.97. The stock has a 50-day moving average price of $67.18 and a 200-day moving average price of $64.18. JPMorgan U.S. Research Enhanced Large Cap ETF has a 1 year low of $56.88 and a 1 year high of $69.78.
JPMorgan U.S. Research Enhanced Large Cap ETF Company Profile
The JPMorgan ActiveBuilders U.S. Large Cap Equity ETF (JUSA) is an exchange-traded fund that mostly invests in large cap equity. The fund actively selects US large-cap equities using a top-down and bottom-up approach in seeking to provide long-term capital appreciation. JUSA was launched on Jul 7, 2021 and is managed by JPMorgan Chase.
Read More
- Five stocks we like better than JPMorgan U.S. Research Enhanced Large Cap ETF
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for JPMorgan U.S. Research Enhanced Large Cap ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for JPMorgan U.S. Research Enhanced Large Cap ETF and related companies with MarketBeat.com's FREE daily email newsletter.
